glycoprotein targets

GO! Astellas picks up partner in convertibleCAR for backloaded $780M antibody project
Fierce Biotech
Wed, 06/1/22 - 09:53 am
Astellas
immuno-oncology
R&D
Go Therapeutics
glycoprotein targets